SCHEMBL21477571

SCHEMBL21477571

CCc1ncc2c(n1)C=CC2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26781888 0.70 — —
SCHEMBL21477549 0.68 — —
SCHEMBL24803727 0.67 HTR2C (0.43) —
SCHEMBL10272062 0.64 CDK5 (0.47) —
SCHEMBL10272451 0.64 CDK5 (0.43) —
SCHEMBL19345849 0.63 HDAC1 (0.32) —
SCHEMBL24197819 0.63 CDK5 (0.46) —
SCHEMBL12826117 0.63 CDK5 (0.46) —
SCHEMBL19304369 0.63 HTR2C (0.41) —
SCHEMBL13165358 0.61 GRM5 (0.37) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3838897-A2 (HETERO)ARYLAMIDE COMPOUND FOR INHIBITING PROTEIN KINASE ACTIVITY Shenzhen TargetRx, Inc. (CN) 2021-06-23 — — EP disclosed
EP-3553056-A1 (HETERO)ARYLAMIDE COMPOUND FOR INHIBITING PROTEIN KINASE ACTIVITY Shenzhen Targetrx, Inc. (CN) 2019-10-16 — — EP disclosed
Send feedback